Clinical Trial Update: Post-Marketing Surveillance for Crohn's Disease Participants Treated With Stelara (Ustekinumab)

View source ↗

Summary

This clinical trial update summarizes the safety-focused post-marketing surveillance of ustekinumab (Stelara) in Crohn's disease patients; the study has complet…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Crohn Disease

Drugs mentioned

• Stelara (ustekinumab)

Snippet

Sponsor: Janssen Korea, Ltd., Korea | Conditions: Crohn Disease | Status: COMPLETED